vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and WisdomTree, Inc. (WT). Click either name above to swap in a different company.

WisdomTree, Inc. is the larger business by last-quarter revenue ($147.4M vs $75.5M, roughly 2.0× PUMA BIOTECHNOLOGY, INC.). On growth, WisdomTree, Inc. posted the faster year-over-year revenue change (33.2% vs 27.7%). WisdomTree, Inc. produced more free cash flow last quarter ($147.7M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 23.4%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

WisdomTree, Inc. is a global exchange-traded fund (ETF) and exchange-traded product (ETP) sponsor and asset manager with headquarters in New York. WisdomTree launched its first ETFs in June 2006, and became one of the major ETF providers in the United States. WisdomTree sponsors different ETFs that span asset classes and countries worldwide. Categories include: U.S. and International Equity, Currency, Fixed Income and Alternatives.

PBYI vs WT — Head-to-Head

Bigger by revenue
WT
WT
2.0× larger
WT
$147.4M
$75.5M
PBYI
Growing faster (revenue YoY)
WT
WT
+5.5% gap
WT
33.2%
27.7%
PBYI
More free cash flow
WT
WT
$133.3M more FCF
WT
$147.7M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
23.4%
WT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
WT
WT
Revenue
$75.5M
$147.4M
Net Profit
$40.0M
Gross Margin
69.3%
Operating Margin
22.7%
40.5%
Net Margin
27.1%
Revenue YoY
27.7%
33.2%
Net Profit YoY
46.6%
EPS (diluted)
$0.26
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
WT
WT
Q4 25
$75.5M
$147.4M
Q3 25
$54.5M
$125.6M
Q2 25
$52.4M
$112.6M
Q1 25
$46.0M
$108.1M
Q4 24
$59.1M
$110.7M
Q3 24
$80.5M
$113.2M
Q2 24
$47.1M
$107.0M
Q1 24
$43.8M
$96.8M
Net Profit
PBYI
PBYI
WT
WT
Q4 25
$40.0M
Q3 25
$8.8M
$19.7M
Q2 25
$5.9M
$24.8M
Q1 25
$3.0M
$24.6M
Q4 24
$27.3M
Q3 24
$20.3M
$-4.5M
Q2 24
$-4.5M
$21.8M
Q1 24
$-4.8M
$22.1M
Gross Margin
PBYI
PBYI
WT
WT
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
WT
WT
Q4 25
22.7%
40.5%
Q3 25
17.6%
36.3%
Q2 25
12.7%
30.8%
Q1 25
8.7%
31.6%
Q4 24
22.6%
31.7%
Q3 24
27.4%
36.0%
Q2 24
-4.6%
31.3%
Q1 24
-5.3%
28.9%
Net Margin
PBYI
PBYI
WT
WT
Q4 25
27.1%
Q3 25
16.2%
15.7%
Q2 25
11.2%
22.0%
Q1 25
6.5%
22.8%
Q4 24
24.7%
Q3 24
25.2%
-4.0%
Q2 24
-9.6%
20.3%
Q1 24
-11.0%
22.8%
EPS (diluted)
PBYI
PBYI
WT
WT
Q4 25
$0.26
$0.28
Q3 25
$0.17
$0.13
Q2 25
$0.12
$0.17
Q1 25
$0.06
$0.17
Q4 24
$0.40
$0.20
Q3 24
$0.41
$-0.13
Q2 24
$-0.09
$0.13
Q1 24
$-0.10
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
WT
WT
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$413.7M
Total Assets
$216.3M
$1.5B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
WT
WT
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
$132.5M
Q1 24
$107.2M
$116.9M
Total Debt
PBYI
PBYI
WT
WT
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
WT
WT
Q4 25
$130.3M
$413.7M
Q3 25
$115.3M
$373.4M
Q2 25
$104.7M
$445.1M
Q1 25
$97.1M
$415.6M
Q4 24
$92.1M
$400.0M
Q3 24
$71.1M
$374.9M
Q2 24
$48.5M
$445.6M
Q1 24
$51.0M
$423.2M
Total Assets
PBYI
PBYI
WT
WT
Q4 25
$216.3M
$1.5B
Q3 25
$202.9M
$1.4B
Q2 25
$194.9M
$1.1B
Q1 25
$196.2M
$1.0B
Q4 24
$213.3M
$1.0B
Q3 24
$220.7M
$1.0B
Q2 24
$205.0M
$964.1M
Q1 24
$214.1M
$931.7M
Debt / Equity
PBYI
PBYI
WT
WT
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
WT
WT
Operating Cash FlowLast quarter
$14.4M
$147.9M
Free Cash FlowOCF − Capex
$14.4M
$147.7M
FCF MarginFCF / Revenue
19.1%
100.2%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
3.70×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$240.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
WT
WT
Q4 25
$14.4M
$147.9M
Q3 25
$9.7M
$48.1M
Q2 25
$14.1M
$38.8M
Q1 25
$3.6M
$6.4M
Q4 24
$15.6M
$113.5M
Q3 24
$11.0M
$47.7M
Q2 24
$1.0M
$32.2M
Q1 24
$11.2M
$-1.0M
Free Cash Flow
PBYI
PBYI
WT
WT
Q4 25
$14.4M
$147.7M
Q3 25
$9.7M
$48.0M
Q2 25
$14.1M
$38.7M
Q1 25
$3.6M
$6.3M
Q4 24
$15.6M
$113.3M
Q3 24
$11.0M
$47.7M
Q2 24
$1.0M
$32.2M
Q1 24
$-1.1M
FCF Margin
PBYI
PBYI
WT
WT
Q4 25
19.1%
100.2%
Q3 25
17.7%
38.2%
Q2 25
26.8%
34.4%
Q1 25
7.7%
5.9%
Q4 24
26.4%
102.4%
Q3 24
13.7%
42.1%
Q2 24
2.1%
30.1%
Q1 24
-1.1%
Capex Intensity
PBYI
PBYI
WT
WT
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.1%
Q1 25
0.1%
0.0%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.1%
Cash Conversion
PBYI
PBYI
WT
WT
Q4 25
3.70×
Q3 25
1.10×
2.44×
Q2 25
2.41×
1.57×
Q1 25
1.21×
0.26×
Q4 24
4.15×
Q3 24
0.54×
Q2 24
1.48×
Q1 24
-0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

WT
WT

Investment Advisory Management And Administrative Service$122.7M83%
Other Services Income$12.7M9%
IE$11.5M8%

Related Comparisons